drugset / Trial / NCT00896168
An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid Arthritis
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the effectiveness of iInfliximab plus methotrexate (MTX) in treatment of Rheumatoid rheumatoid Arthritis arthritis (RA) (it is an autoimmune disease that causes pain, swelling, stiffness and loss of function in joints) in participants with moderate disease versus participants with severe disease and to compare the efficacy and safety of the MTX subgroups.
Timeline
- Start
- 2007-06
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Infliximab | Monoclonal antibody | 3 mg/kg | Intravenous |
| Subject | Methotrexate | Small molecule | 7.5 mg | Oral |
| Subject | Methotrexate | Small molecule | 20 mg | Oral |